Financial information

The information source is the annual report of the company with business id 556713-3425

* Closing information (×1000) SEK

Fiscal year 202503 202403 (consolidated) 202303 (consolidated)
Number of months: 12 12
Turnover: 373,516 Revenue Up 264,168 Revenue Up 259,913
Financial expenses: 13,022 Revenue Up 5,732 Revenue Up 2,372
Earnings before taxes: 54,354 Revenue Up 28,604 Revenue Down 38,968
Total assets: 808,823 Revenue Up 373,759 Revenue Up 285,696
Current assets: 400,252 Revenue Up 197,774 Revenue Up 167,228
Current liabilities: 221,018 Revenue Up 162,050 Revenue Up 115,976
Equity capital: 221,035 Revenue Up 177,726 Revenue Up 154,753
Share capital: 1,308 1,308 1,308
Number of employees: 21 21 Revenue Up 18

Financial ratios

Solvency: 27.3% Revenue Down 47.6% Revenue Down 54.2%
Turnover per employee: 17,786 Revenue Up 12,579 Revenue Down 14,440
Profitability: 14.6% Revenue Up 10.8% Revenue Down 15.0%
Return on equity (ROE): 24.6% Revenue Up 16.1% Revenue Down 25.2%
Current ratio: 181.1% Revenue Up 122.0% Revenue Down 144.2%
Return on assets (ROA): 8.3% Revenue Down 9.2% Revenue Down 14.5%

Companies with similar products and services, and with detailed information

  • Solveco AB

    Pharmaceuticals. Medicinal chemicals. Botanical produc...

Fiscal year 202503
Number of months: 12
Turnover: 373,516
Financial expenses: 13,022
Earnings before taxes: 54,354
Total assets: 808,823
Current assets: 400,252
Current liabilities: 221,018
Equity capital: 221,035
Share capital: 1,308
Number of employees: 21

Financial ratios

Solvency: 27.3%
Turnover per employee: 17,786
Profitability: 14.6%
Return on equity (ROE): 24.6%
Current ratio: 181.1%
Return on assets (ROA): 8.3%